Cost-effectiveness estimates for antenatal HIV testing in the Netherlands
Authors:
- 1 October 2008
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 19 (10) , 668-675
Abstract
This paper provides an estimation of the lifetime healthcare cost of HIV-infected children and an update of the cost-effectiveness of universal HIV-screening of pregnant women in Amsterdam (The Netherlands). During 2003–2005, we collected data concerning the prevalence of newly diagnosed HIV-infected pregnant women in Amsterdam. Also, data on resource utilization and HAART regimen for HIV-infected children was gathered from a national registry. Using Kaplan-Meier survival analysis, we estimated the life-expectancy of a vertically HIV-infected child at 19 years, with the corresponding lifetime healthcare costs of €179,974. HIV-screening of pregnant women could prevent 2.4 HIV transmissions annually in Amsterdam, based on an estimated prevalence of nine yet undiagnosed HIV-positive pregnant women per 10,000 pregnancies. We show that universal HIV screening during pregnancy generates significant net cost savings and health benefits in most situations. Universal antenatal HIV screening is justified in Amsterdam from a health-economic point of view.Keywords
This publication has 37 references indexed in Scilit:
- Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission StudyThe Journal of Infectious Diseases, 2006
- Clinical Outcomes Improve with Highly Active Antiretroviral Therapy in Vertically HIV Type‐1–Infected ChildrenClinical Infectious Diseases, 2006
- Distribution of Health Care Expenditures for HIV-Infected PatientsClinical Infectious Diseases, 2006
- Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingVaccine, 2004
- Would Universal Antenatal Screening for HIV Infection Be Cost‐Effective in a Setting of Very Low Prevalence? Modelling the Data for AustraliaThe Journal of Infectious Diseases, 2004
- Cost-Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal CareMedical Decision Making, 2004
- Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandBMJ, 2003
- The cost effectiveness of universal antenatal screening for HIV in New ZealandAIDS, 2003
- NOTES AND QUOTESAIDS, 2002
- Rates of Mother-to-Child Transmission of HIV-1 in Africa, America, and EuropeJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995